Axoft
Company · Cambridge, Massachusetts, USA
Develops ultra-soft implantable electrodes designed to move with brain tissue and reduce scarring over time.
Axoft’s materials are much softer than conventional silicon or metal probes, aiming for stable recordings that last for years. It has reported early first-in-human recordings.
In the news
ImplantsResearch
Axoft reports early human recordings with its soft Fleuron brain probes
The company says short-term recordings in 12 surgical patients in Boston and Panama showed stable, high-yield signals, presented at three fall neuroscience meetings.
FundingImplants
Axoft raises $55 million after implanting its ultra-soft brain probes in more than 11 patients
The Series A, led by C.P. Group Innovation, funds global trials and manufacturing of its Fleuron-based implantable BCI.